Presentation for the Investors / Analysts on Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.

Investor Presentation - Q1 FY27 - Standalone revenue Rs 350 Cr +18.7% y-y; EBITDA Rs 61.9 Cr +42.0% y-y; PAT Rs 42.4 Cr +60.7% y-y; EBITDA margin 17.7%, PAT margin 11.8% - Growth driven by double-digit value and volume increases across product categories - Gross margin strong at 45.3% despite volatile raw material costs; cost optimization aided margin expansion - Capacity expansion underway with new water-based plant trial production starting Aug 2026 - Outlook: expect growth premium over industry via trade discounts and influencer spends; Apple Chemie margins to improve Q2 FY27; minimal capex through 2029; focus on brand equity and price management